NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

NOVN.CH

96.21

+0.07%↑

SOON.CH

239

-0.17%↓

Search

Roche Holding AG

Uždarymo kaina

SektoriusSveikatos priežiūra

277.4 -0.29

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

276.4

Max

280

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-4.2B

2B

Pardavimai

-109M

31B

P/E

Sektoriaus vid.

26.874

50.291

Dividendų pajamingumas

3.5

Pelno marža

6.588

Darbuotojai

103,249

EBITDA

-4.6B

6B

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

3.50%

2.40%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-11B

208B

Ankstesnė atidarymo kaina

277.69

Ankstesnė uždarymo kaina

277.4

Naujienos nuotaikos

By Acuity

22%

78%

45 / 380 reitingas Healthcare

Roche Holding AG Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-06-11 08:25; UTC

Įsigijimai, susijungimai, perėmimai

EQT, Sanofi Co-Led $135 Million Funding Round for Spanish Biotech Company SpliceBio

2025-05-12 02:16; UTC

Pagrindinės rinkos jėgos

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

2025-04-24 07:30; UTC

Uždarbis

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

2025-04-24 05:31; UTC

Uždarbis

Roche Sales Rise Boosted By Key Drugs

2025-04-09 09:39; UTC

Pagrindinės rinkos jėgos

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

2025-03-12 09:23; UTC

Pagrindinės rinkos jėgos

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

2025-01-30 09:36; UTC

Uždarbis

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

2025-01-30 06:32; UTC

Uždarbis

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

2025-06-16 08:55; UTC

Karštos akcijos

Stocks to Watch: Victoria's Secret, Renault, U.S. Steel, Sarepta -- WSJ

2025-06-03 07:51; UTC

Rinkos pokalbiai

Roche Unlikely to Get Revenue Boost From Tecentriq Combination With Lurbinectedin -- Market Talk

2025-05-21 07:20; UTC

Rinkos pokalbiai

Roche Lymphoma Drug Columvi Dealt Setback by FDA Committee -- Market Talk

2025-05-02 06:25; UTC

Rinkos pokalbiai
Uždarbis

Roche Shows Pipeline Progress But Near-Term Risks Remain -- Market Talk

2025-04-24 09:39; UTC

Rinkos pokalbiai
Uždarbis

Roche's Pipeline in Focus After Solid Results -- Market Talk

2025-04-24 09:24; UTC

Rinkos pokalbiai
Uždarbis

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

2025-04-24 09:18; UTC

Rinkos pokalbiai
Uždarbis

Roche's Results Are Solid -- Market Talk

2025-04-24 05:16; UTC

Svarbiausios naujienos

Roche Sales Rise, Boosted By Key Drugs

2025-04-22 10:51; UTC

Svarbiausios naujienos

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

2025-04-15 09:55; UTC

Rinkos pokalbiai

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

2025-04-09 10:03; UTC

Rinkos pokalbiai
Uždarbis

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

2025-04-09 07:23; UTC

Rinkos pokalbiai

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

2025-04-03 08:41; UTC

Rinkos pokalbiai

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

2025-04-03 07:51; UTC

Rinkos pokalbiai

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

2025-03-31 09:31; UTC

Karštos akcijos

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

2025-03-13 07:46; UTC

Rinkos pokalbiai

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

2025-03-12 16:34; UTC

Svarbiausios naujienos

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

2025-03-12 08:51; UTC

Rinkos pokalbiai

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

2025-03-12 08:18; UTC

Rinkos pokalbiai

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

2025-02-13 11:43; UTC

Rinkos pokalbiai

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

2025-01-30 07:56; UTC

Rinkos pokalbiai
Uždarbis

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

2025-01-30 06:04; UTC

Uždarbis

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

Akcijų palyginimas

Kainos pokytis

Roche Holding AG Prognozė

Rinkos nuotaikos

By Acuity

45 / 380 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.